Finasteride NDC# 82187-1003-1 Container Description: The product… — Class II drug recall D-0262-2025
Ongoing recall by Aspen Biopharma Labs Pvt., Ltd., reported 2025-03-19, distributed in FL. CGMP Deviations
| Recall number | D-0262-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Aspen Biopharma Labs Pvt., Ltd., Medchal Malkajgiri, India |
| Recall initiated | 2025-02-07 |
| Classified | 2025-03-09 |
| Reported by FDA | 2025-03-19 |
| Distributed | FL |
| Countries outside the US | HK |
| Quantity | 120 kilograms |
| Reason classes | cgmp |
| NDC | 82187-1003-01 |
| Lot numbers | AUG-2027, HAFSC0040923, HAFSC0050923 |
Product
Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0262-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.